- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring
Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More
DarioHealth Integrates Blood Glucose Data with Glytec’s Outpatient Insulin Management Solution
DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More
OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU
OptiScan Biomedical, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU) has raised $20 million in Series E funding. The company plans to use the funding to support the commercialization of the company’s lead product, the OptiScanner 5000, in the United States. OptiScan will also use a portion of the funding to continue the expansion of the company’s OptiScanner platform to monitor additional analytes of interest for critically ill
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
Glooko Launches Integration with Novo Nordisk Insulin Pen
Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report. With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar for patient convenience even further, Glooko is launching the ability to also upload pen data remotely – straight from any near field
Read More
DexCom Integrates Continuous Glucose Monitoring Data with Validic Data Connectivity Platform
DexCom, Inc., a provider of continuous glucose monitoring (CGM) solutions, announced a partnership with data integration platform Validic. As part of the partnership, DexCom will integrate CGM data from Dexcom’s cloud API is integrated into the Validic’s connectivity platform to establish a multi-measure platform to stream in-home clinical data directly into clinical workflows and systems. This partnership is part of a larger effort to improve the interoperability of clinical systems and provide
Read More
Livongo Health and Abbott Partner to Offer Continuous Glucose Monitoring Insights
Livongo Health, a consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.Through this integration collaboration, Livongo will offer, where appropriate and prescribed, the FreeStyle Libre
Read More
Smart Meter’s Diabetes Care Solution Meets Newly Created Remote Monitoring CPT Code
Smart Meter, an innovative diabetes management data, technology and solutions company, today announced that its iGlucose® Diabetes Care Solution meets the requirements for the newly created Remote Monitoring CPT Code, as defined by Centers of Medicare and Medicaid Services (CMS). The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, is providing clinicians with another tool for making connected health more available and more widely
Read More
FDA Approves Medtronic Smart Continuous Glucose Monitoring (CGM) System for Diabetes
The FDA has just approved the Medtronic Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart CGM system to help people with diabetes outsmart high and low glucose events. The system uses the power of real-time sensor glucose data, advanced algorithms and customizable, predictive alerts to notify people when sensor glucose levels are predicted to go too high or low – up to 60 minutes in advance.Understanding Continuous Glucose Monitoring (CGM)A CGM system provides
Read More